Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
311
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Henlius Biotech
•
23 Sep 2024 00:18
Merger Arb Mondays (23 Sep) - Henlius, GA Pack, China TCM, Canvest, Trancom, Fuji Soft, Platinum
This week, the highest gross spreads are Canvest (8.6%), Shinko Electric (7.2%), GA Pack (6.9%), Henlius (6.7%), China TCM (5.7%), Capitol Health...
Arun George
Follow
532 Views
Share
bullish
•
China Traditional Chinese Medicine
•
16 Sep 2024 00:41
Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac
This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...
Arun George
Follow
668 Views
Share
bullish
•
Shanghai Henlius Biotech
•
10 Sep 2024 08:55
Shanghai Henlius Biotech (2696.HK) Privatization Update - Some New Information Worth the Attention
Fosun Pharma will make every effort to promote the success of privatization due to plans for Henlius internal integration with Fosun Pharma and...
Xinyao (Criss) Wang
Follow
691 Views
Share
bullish
•
Shinko Electric Industries
•
09 Sep 2024 00:39
Merger Arb Mondays (09 Sep) - Shinko, Fuji Soft, Pasco, GA Pack, CPMC, Latin Res, Capitol, PSC, Rex
This week, the highest gross spreads are HEC Pharma (116.0%), Canvest (8.4%), Shinko Electric (7.9%), Malaysia Airports (7.4%), GA Pack (6.9%),...
Arun George
Follow
539 Views
Share
bearish
•
Shanghai Fosun Pharmaceutical (Group)
•
08 Sep 2024 09:12
China Healthcare Weekly (Sep.8) - Fosun Pharma, Medical Device Outlook, Biotech Investment Criteria
Business model of medical devices is shifting, leading to potential underperformance. There's a gap between Chinese Biotech and top players....
Xinyao (Criss) Wang
Follow
470 Views
Share
First
Previous
33
34
35
36
37
38
39
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x